SCHEMBL26837276

SCHEMBL26837276

Fc1cc2c3c([nH]c2cc1Cl)C1CCCN(CC3)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 2/20 0.39
▸ KIF11 P52732 1/20 0.33
▸ HTR3A P46098 2/20 0.33
▸ CHRNA7 P36544 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ ABCB1 P08183 1/20 0.32
▸ ABCG2 Q9UNQ0 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ ALOX15 P16050 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ BRD3 Q15059 2/20 0.32
▸ HTR2A P28223 3/20 0.32
▸ HTR2C P28335 3/20 0.32
▸ ADRA1D P25100 1/20 0.32
▸ ADRA1A P35348 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26837273 0.95 AR (0.34) ARKIF11HTR3ACHRNA7ABCB1
SCHEMBL26837304 0.90 ADRA1D (0.34) KIF11CHRNA7ABCB1ABCG2MEN1
SCHEMBL26837280 0.90 AR (0.35) ARKIF11ABCG2MAPTALOX15
SCHEMBL26837291 0.86 BRD3 (0.35) CHRNA7BRD3ADRA1DADRA1AADRA1B
SCHEMBL26837269 0.86 MAPT (0.34) MAPTALOX15SMN1; SMN2MEN1GLA
SCHEMBL26837294 0.83 BRD3 (0.35) KIF11CHRNA7BRD3ADRA1DADRA1A
SCHEMBL26837266 0.83 MAPT (0.34) MAPTALOX15SMN1; SMN2MEN1GLA
SCHEMBL26839913 0.83 MAPT (0.38) HTR3AABCB1ABCG2MAPTHTR2A
SCHEMBL26837287 0.81 ALOX15 (0.40) KIF11MAPTALOX15SMN1; SMN2MEN1
SCHEMBL26837307 0.81 HTR2A (0.41) KCNH2ABCB1ABCG2BRD3HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382919-A1 OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-11-30 — — US disclosed
US-20230382919-A1 OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382919-A1 OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS GRIA4, GRIA3, GRIN3A AR 273/4885KIF11 3986/4885HTR3A 108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback